Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients☆
To access this article, please choose from the options below
☆ The authors who have taken part in the research of this paper declared that they do not have a relationship with the manufacturers of the drugs involved either in the past or present and they did not receive funding from the manufacturers to carry out their research.
PII: S0168-8278(09)00055-5
doi:10.1016/j.jhep.2008.12.017
© 2009 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
